The experts group stats & facts
Experts
Countries
Publications
Recent updates
From Ovarian to Endocrine-Metabolic Roots: Aligning PCOS Nomenclature with Pathophysiology
Authors: Unfer, V.

First EGOI-PCOS School and Third EGOI-PCOS Society Meeting Held in Greece
Authors: EGOI Members
PCOS phenotype focus: phenotype D under the magnifying glass
Authors: Myers SH, Montanino Oliva M, Nordio M, Unfer V.
Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
Authors: Geraci Giovanna , Riccio Carmine , Oliva Fabrizio , Gabrielli Domenico , Colivicchi Furio , Grimaldi Massimo , Facchinetti Fabio , Unfer Vittorio
Effect of 40:1 myo-inositol/D-chiro-inositol treatment on serum asprosin levels in polycystic ovary syndrome: a prospective randomized pilot study
Authors: Ozay OE, Ozay Y, Edebal O, Calcagno M, Ozay AC.
The Clinical Use of Myo-Inositol in IVF-ET: A Position Statement from the Experts Group on Inositol in Basic and Clinical Research and on PCOS (EGOI-PCOS), the Polish Society of Andrology, and the International Scientific Association for the Support and Development of Medical Technologies
Authors: Wdowiak A, Bakalczuk S, Filip M, Laganà AS, Unfer V.

EGOI-PCOS Joins the International Network of FISGE
Authors: EGOI Members
Inositols and Bone Health: Potential Therapeutic Applications in Osteoporosis Prevention and Treatment
Authors: Cipriani, F.; Gnessi, L.; Watanabe, M.; Baldelli, R.
PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review.
Authors: Lentini G, Querqui A, Monti N, Bizzarri M.
Insights from the EGOI-PCOS patient survey: Diagnosis, treatment, and quality of life according to Italian PCOS patients
Authors: Carriero VC, Forte G, Dinicola S, Oliva MM, Al Mudarris G., Unfer V.